アンジオテンシンII受容体拮抗薬用非ペプチド薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C4041
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、136ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、アンジオテンシンII受容体拮抗薬用非ペプチド薬の世界市場について調べ、まとめました。種類別セグメントは、バルサルタン、イルベサルタン、カンデサルタンシレキセチル、エプロサルタン、イルベサルタン、テルミサルタン、ロサルタン、オルメサルタンメドキソミル、アリサルタンイソプロキシル等、用途別セグメントは、等に区分しました。アンジオテンシンII受容体拮抗薬用非ペプチド薬の世界市場概観、企業動向、企業別アンジオテンシンII受容体拮抗薬用非ペプチド薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の市場概観
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の企業別販売動向、市場シェア、市場集中度、競争動向
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の世界市場規模
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のアメリカ市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のカナダ市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のメキシコ市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のドイツ市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のイギリス市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のロシア市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の日本市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の中国市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の韓国市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬のインド市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の東南アジア市場規模推移
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の南米市場分析（ブラジル、アルゼンチン等）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の種類別分析/販売量、売上、市場シェア（バルサルタン、イルベサルタン、カンデサルタンシレキセチル、エプロサルタン、イルベサルタン、テルミサルタン、ロサルタン、オルメサルタンメドキソミル、アリサルタンイソプロキシル）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の用途別分析/市場規模（）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・アンジオテンシンII受容体拮抗薬用非ペプチド薬の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Non-Peptide Drugs of Angiotensin II Receptor Antagonist market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-Peptide Drugs of Angiotensin II Receptor Antagonist.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Non-Peptide Drugs of Angiotensin II Receptor Antagonist market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-Peptide Drugs of Angiotensin II Receptor Antagonist market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Novartis
Merck
AstraZeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Sun Pharmaceutical
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Amneal Pharmaceuticals
Boehringer Ingelheim

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Valsartan
Irbesartan
Candesartan Cilexetil
Eprosartan
Irbesartan
Telmisartan
losartan
Olmesartan Medoxomil
Allisartan isoproxil

Market Segment by Applications, can be divided into
High Blood Pressure
Congestive Heart Failure
Left Ventricular Hypertrophy
Atherosclerosis
Other

レポート目次

Table of Contents

1 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Overview
1.1 Product Overview and Scope of Non-Peptide Drugs of Angiotensin II Receptor Antagonist
1.2 Classification of Non-Peptide Drugs of Angiotensin II Receptor Antagonist by Types
1.2.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Comparison by Types (2019-2024)
1.2.2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Types in 2018
1.2.3 Valsartan
1.2.4 Irbesartan
1.2.5 Candesartan Cilexetil
1.2.6 Eprosartan
1.2.7 Irbesartan
1.2.8 Telmisartan
1.2.9 losartan
1.2.10 Olmesartan Medoxomil
1.2.11 Allisartan isoproxil
1.3 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market by Application
1.3.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 High Blood Pressure
1.3.3 Congestive Heart Failure
1.3.4 Left Ventricular Hypertrophy
1.3.5 Atherosclerosis
1.3.6 Other
1.4 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market by Regions
1.4.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Non-Peptide Drugs of Angiotensin II Receptor Antagonist Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-Peptide Drugs of Angiotensin II Receptor Antagonist Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-Peptide Drugs of Angiotensin II Receptor Antagonist Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Non-Peptide Drugs of Angiotensin II Receptor Antagonist Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-Peptide Drugs of Angiotensin II Receptor Antagonist Status and Prospect (2014-2024)
1.5 Global Market Size of Non-Peptide Drugs of Angiotensin II Receptor Antagonist (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck
2.3.1 Business Overview
2.3.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.4 AstraZeneca
2.4.1 Business Overview
2.4.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.5 Jhonson and Johnson
2.5.1 Business Overview
2.5.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Jhonson and Johnson Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bayer
2.9.1 Business Overview
2.9.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bayer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.10 GSK
2.10.1 Business Overview
2.10.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GSK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.11 Teva Pharmaceutical
2.11.1 Business Overview
2.11.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Teva Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.12 Shenzhen Salubris Pharmaceuticals
2.12.1 Business Overview
2.12.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Shenzhen Salubris Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.13 Sun Pharmaceutical
2.13.1 Business Overview
2.13.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sun Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.14 Mylan
2.14.1 Business Overview
2.14.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Mylan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.15 Alembic Pharmaceuticals
2.15.1 Business Overview
2.15.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Alembic Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.16 Lupin
2.16.1 Business Overview
2.16.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Lupin Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.17 Aurobindo Pharma
2.17.1 Business Overview
2.17.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Aurobindo Pharma Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.18 Amneal Pharmaceuticals
2.18.1 Business Overview
2.18.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Amneal Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
2.19 Boehringer Ingelheim
2.19.1 Business Overview
2.19.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Boehringer Ingelheim Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
3 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Competition, by Players
3.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Players Market Share
3.2.2 Top 10 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Players Market Share
3.3 Market Competition Trend
4 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size by Regions
4.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Market Share by Regions
4.2 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
4.3 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
4.5 South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
5 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries
5.1 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries (2014-2019)
5.2 USA Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
5.3 Canada Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
5.4 Mexico Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
6 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries
6.1 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries (2014-2019)
6.2 Germany Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
6.3 UK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
6.4 France Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
6.5 Russia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
6.6 Italy Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries
7.1 Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries (2014-2019)
7.2 China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
7.3 Japan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
7.4 Korea Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
7.5 India Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
8 South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries
8.1 South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries (2014-2019)
8.2 Brazil Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
8.3 Argentina Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
8.4 Colombia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Non-Peptide Drugs of Angiotensin II Receptor Antagonist by Countries
9.1 Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries (2014-2019)
9.2 Saudi Arabia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
9.3 UAE Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
9.4 Egypt Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
9.5 Nigeria Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
9.6 South Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
10 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Segment by Type
10.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Market Share by Type (2014-2019)
10.2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Forecast by Type (2019-2024)
10.3 Valsartan Revenue Growth Rate (2014-2024)
10.4 Irbesartan Revenue Growth Rate (2014-2024)
10.5 Candesartan Cilexetil Revenue Growth Rate (2014-2024)
10.6 Eprosartan Revenue Growth Rate (2014-2024)
10.7 Irbesartan Revenue Growth Rate (2014-2024)
10.8 Telmisartan Revenue Growth Rate (2014-2024)
10.9 losartan Revenue Growth Rate (2014-2024)
10.10 Olmesartan Medoxomil Revenue Growth Rate (2014-2024)
10.11 Allisartan isoproxil Revenue Growth Rate (2014-2024)
11 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Segment by Application
11.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Application (2014-2019)
11.2 Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Forecast by Application (2019-2024)
11.3 High Blood Pressure Revenue Growth (2014-2019)
11.4 Congestive Heart Failure Revenue Growth (2014-2019)
11.5 Left Ventricular Hypertrophy Revenue Growth (2014-2019)
11.6 Atherosclerosis Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)
12 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size Forecast (2019-2024)
12.1 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Size Forecast (2019-2024)
12.2 Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Forecast by Regions (2019-2024)
12.3 North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
12.4 Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
12.6 South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Non-Peptide Drugs of Angiotensin II Receptor Antagonist Picture
Table Product Specifications of Non-Peptide Drugs of Angiotensin II Receptor Antagonist
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist and Revenue (Million USD) Market Split by Product Type
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Types in 2018
Figure Valsartan Picture
Figure Irbesartan Picture
Figure Candesartan Cilexetil Picture
Figure Eprosartan Picture
Figure Irbesartan Picture
Figure Telmisartan Picture
Figure losartan Picture
Figure Olmesartan Medoxomil Picture
Figure Allisartan isoproxil Picture
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) by Application (2014-2024)
Figure Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Applications in 2018
Figure High Blood Pressure Picture
Figure Congestive Heart Failure Picture
Figure Left Ventricular Hypertrophy Picture
Figure Atherosclerosis Picture
Figure Other Picture
Table Global Market Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Pfizer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Novartis Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Merck Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table AstraZeneca Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table Jhonson and Johnson Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Jhonson and Johnson Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Eli Lilly Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Sanofi Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Bristol-Myers Squibb Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Bayer Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table GSK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Teva Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Shenzhen Salubris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Shenzhen Salubris Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Shenzhen Salubris Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Sun Pharmaceutical Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Mylan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alembic Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Alembic Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Lupin Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Aurobindo Pharma Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Amneal Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Amneal Pharmaceuticals Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Non-Peptide Drugs of Angiotensin II Receptor Antagonist Type and Applications
Table Boehringer Ingelheim Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2018)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) by Players (2014-2019)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Players (2014-2019)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Players in 2017
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Players in 2018
Figure Global Top 5 Players Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share in 2018
Figure Global Top 10 Players Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share in 2018
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) by Regions (2014-2019)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Regions (2014-2019)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Regions (2014-2019)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Regions in 2018
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Table North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries (2014-2019)
Table North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries (2014-2019)
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries (2014-2019)
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries in 2018
Figure USA Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Canada Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Mexico Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Table Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) by Countries (2014-2019)
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries (2014-2019)
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries in 2018
Figure Germany Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure UK Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure France Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Russia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Italy Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries in 2018
Figure China Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Japan Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Korea Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure India Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Table South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Countries (2014-2019)
Table South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries (2014-2019)
Figure South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries (2014-2019)
Figure South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries in 2018
Figure Brazil Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Argentina Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Colombia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share by Countries in 2018
Figure Saudi Arabia Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure UAE Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Egypt Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure Nigeria Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Figure South Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue and Growth Rate (2014-2019)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) by Type (2014-2019)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Type (2014-2019)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Type (2014-2019)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Type in 2018
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Forecast by Type (2019-2024)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Share Forecast by Type (2019-2024)
Figure Global Valsartan Revenue Growth Rate (2014-2019)
Figure Global Irbesartan Revenue Growth Rate (2014-2019)
Figure Global Candesartan Cilexetil Revenue Growth Rate (2014-2019)
Figure Global Eprosartan Revenue Growth Rate (2014-2019)
Figure Global Irbesartan Revenue Growth Rate (2014-2019)
Figure Global Telmisartan Revenue Growth Rate (2014-2019)
Figure Global losartan Revenue Growth Rate (2014-2019)
Figure Global Olmesartan Medoxomil Revenue Growth Rate (2014-2019)
Figure Global Allisartan isoproxil Revenue Growth Rate (2014-2019)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue by Application (2014-2019)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Application (2014-2019)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Application (2014-2019)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Share by Application in 2018
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Forecast by Application (2019-2024)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Market Share Forecast by Application (2019-2024)
Figure Global High Blood Pressure Revenue Growth Rate (2014-2019)
Figure Global Congestive Heart Failure Revenue Growth Rate (2014-2019)
Figure Global Left Ventricular Hypertrophy Revenue Growth Rate (2014-2019)
Figure Global Atherosclerosis Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
Figure Europe Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
Figure South America Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Non-Peptide Drugs of Angiotensin II Receptor Antagonist Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介

世界のN-ホルミルペプチド受容体2市場2019

Global N-Formyl Peptide Receptor 2 Sales Market Report 2019
QYR9N2883 2019年6月13日 100Pages
本調査レポートでは、N-ホルミルペプチド受容体2の世界市場について調査・分析し、N-ホルミルペプチド受容体2のメーカー別販売量、市場シェア分析、種類別販売分析（TR-8、NCP-70X、ヒューマニン、その他）、用途別販売分析（炎症、2型糖尿病、アレルギー、脳虚血、転移性がん、その他）、地域別販売分析...

大豆プロテインパウダー（大豆ペプチドパウダー）の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Soy Protein Powder(Soy Peptide Powder) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C5406 2019年8月 138Pages
本調査レポートは、大豆プロテインパウダー（大豆ペプチドパウダー）の世界市場について調べ、まとめました。種類別セグメントは、食品グレード、原料グレード等、用途別セグメントは、栄養補助食品、飲料及び乳製品、その他等に区分しました。大豆プロテインパウダー（大豆ペプチドパウダー）の世界市場概観、企業動向、企...

P2X 7受容体アンタゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global P2X7 Receptor Antagonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4251 2019年7月 118Pages
本調査レポートは、P2X 7受容体アンタゴニストの世界市場について調べ、まとめました。種類別セグメントは、GSK1482160、AZD9056、EVT 401、JNJ 55308942・JNJ 54175446、AKP-23494954 / RQ-00466479、その他等、用途別セグメントは、等に...

世界のペプチドベースの胃腸障害治療薬市場：市場規模・現状・予測

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7787 2019年6月14日 96Pages
当資料は、ペプチドベースの胃腸障害治療薬のグローバル市場について調査・分析したレポートで、種類別（テドグルタイド、リナクロチド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界のペプチドベースのがん治療薬市場：市場規模・現状・予測

Global Peptide Based Cancer Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7786 2019年6月14日 93Pages
当資料は、ペプチドベースのがん治療薬のグローバル市場について調査・分析したレポートで、種類別（ゴセレリン、ボルテゾミブ、ロイプロレリン、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報...

世界のペプチドベースの代謝障害治療薬市場：市場規模・現状・予測

Global Peptide Based Metabolic Disorders Therapeutics Market Size, Status and Forecast 2019-2025
QYR9N7788 2019年6月14日 98Pages
当資料は、ペプチドベースの代謝障害治療薬のグローバル市場について調査・分析したレポートで、種類別（エクセナチド、リラグルチド、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...

キメラ抗原受容体細胞療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Chimeric Antigen Receptor Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1220 2019年7月 138Pages
本調査レポートは、キメラ抗原受容体細胞療法の世界市場について調べ、まとめました。種類別セグメントは、単剤療法、併用療法等、用途別セグメントは、等に区分しました。キメラ抗原受容体細胞療法の世界市場概観、企業動向、企業別キメラ抗原受容体細胞療法シェア、市場規模推移、市場規模予測（2019年-2024年）...

グリコシル化ペプチド市場：世界及び中国市場分析・予測（～2024年）

Glycosylated Peptide Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J04031 2019年7月 138Pages
世界及び中国におけるグリコシル化ペプチド市場について調査・分析したレポートで、グリコシル化ペプチドの世界市場動向、市場規模、主要企業情報などが含まれています。グリコシル化ペプチドの種類別には、モノクローナル抗体（MAB）、エリスロポエチン（EPO）、その他に分けて分析し、地域別には、アメリカ、ヨーロ...

ペプチド核酸市場：世界及び中国の市場分析・予測（～2024年）

Peptide Nucleic Acid Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J08704 2019年7月 143Pages
世界及び中国におけるペプチド核酸市場について調査・分析したレポートで、ペプチド核酸の世界市場動向、市場規模、主要企業情報などが含まれています。ペプチド核酸の種類別・用途別に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。
・ペプチド核酸産業の概要...

血圧障害薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Blood Pressure Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C0858 2019年7月 136Pages
本調査レポートは、血圧障害薬の世界市場について調べ、まとめました。種類別セグメントは、利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体拮抗薬（ARB）、その他等、用途別セグメントは、等に区分しました。血圧障害薬の世界市場概観、企業動向、企業別血圧障害薬シェア、市場規模推移、市...

世界のN-ホルミルペプチド受容体2市場2019 The global N-Formyl Peptide Receptor 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global N-Formyl Peptide Receptor 2 market status and forecast, categorizes the global N-Formyl Peptide Recepto…
グリコシル化ペプチド市場：世界及び中国市場分析・予測（～2024年） Glycosylated Peptide Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Glycosylated Peptide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Glycosylated Peptide manufac…
ペプチド核酸市場：世界及び中国の市場分析・予測（～2024年） Peptide Nucleic Acid Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Peptide Nucleic Acid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Peptide Nucleic Acid manufac…
世界のペプチドベースの胃腸障害治療薬市場：市場規模・現状・予測 Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.In 2018, the global Peptide Based Gastrointestinal Disorders Ther…
世界のペプチドベースのがん治療薬市場：市場規模・現状・予測 Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.In 2018, the global Peptide Based Cancer Therapeutics market size was…